{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:50:27Z","timestamp":1784191827686,"version":"3.55.0"},"reference-count":37,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,5,1]]},"abstract":"<jats:p>Objective. To prevent bacterial endocarditis (BE) in those at risk, the American Heart Association recommends antibiotics for patients who have a known urinary tract infection and are about to undergo urinary catheterization (UC). In young children who have cardiac lesions and undergo UC for fever without a source, the problem with prophylaxis only in the presence of infected urine is that the presence of urinary tract infection is unknown before testing. This study was conducted to determine the cost-effectiveness of BE prophylaxis before UC in febrile children aged 0\u201324 months with moderate-risk cardiac lesions.<\/jats:p><jats:p>Methods. We evaluated the cost-effectiveness of BE prophylaxis compared with no prophylaxis from the societal perspective. Clinical outcomes were based on BE incidence and quality-adjusted life years (QALYs). Probabilities were derived from the medical literature. Costs were derived from national and local sources in US dollars for the reference year 2000, using a discount rate of 3%.<\/jats:p><jats:p>Results. On the basis of the analysis, prophylaxis prevents 7 BE cases per 1 million children treated. When antibiotic-associated deaths were included, the no-prophylaxis strategy was more effective and less costly than the prophylaxis strategy. When antibiotic-associated deaths were excluded, amoxicillin cost $10 million per QALY gained and $70 million per case prevented. For vancomycin, it was $13 million per QALY gained and $95 million per case prevented. The results were robust to variations in the prophylactic efficacy of antibiotics, incidence of bacteremia after UC, incidence of BE after bacteremia, and costs associated with BE prophylaxis and treatment.<\/jats:p><jats:p>Conclusion. In the emergency department, BE prophylaxis before UC in febrile children who are aged 0 to 24 months and have moderate-risk cardiac lesions is not a cost-effective use of health care resources.<\/jats:p>","DOI":"10.1542\/peds.113.5.1291","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:53:04Z","timestamp":1092444784000},"page":"1291-1296","source":"Crossref","is-referenced-by-count":23,"title":["A Cost-Effectiveness Analysis of Bacterial Endocarditis Prophylaxis for Febrile Children Who Have Cardiac Lesions and Undergo Urinary Catheterization in the Emergency Department"],"prefix":"10.1542","volume":"113","author":[{"given":"A. Chantal","family":"Caviness","sequence":"first","affiliation":[{"name":"Section of Pediatric Emergency Medicine, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B.","family":"Cantor","sequence":"additional","affiliation":[{"name":"Section of Health Services Research, Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coburn H.","family":"Allen","sequence":"additional","affiliation":[{"name":"Sections of Pediatric Emergency Medicine and Pediatric Infectious Disease, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Ward","sequence":"additional","affiliation":[{"name":"Sections of Pediatric Emergency Medicine and Pediatric Infectious Disease, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2004,5,1]]},"reference":[{"key":"2021121010043132300_R1","doi-asserted-by":"crossref","unstructured":"Moy RJ, George RH, de Giovanni JV, Silove ED. Improving survival in bacterial endocarditis. Arch Dis Child.\u20081986;61:394\u2013399","DOI":"10.1136\/adc.61.4.394"},{"key":"2021121010043132300_R2","doi-asserted-by":"crossref","unstructured":"Awadallah SM, Kavey RW, Byrum CJ, et al. The changing pattern of infective endocarditis in childhood. Am J Cardiol.\u20081991;68:90\u201394","DOI":"10.1016\/0002-9149(91)90717-Y"},{"key":"2021121010043132300_R3","doi-asserted-by":"crossref","unstructured":"Sholler GF, Hawker RE, Celermajer JM. Infective endocarditis in childhood. Pediatr Cardiol.\u20081986;6:183\u2013186","DOI":"10.1007\/BF02310995"},{"key":"2021121010043132300_R4","doi-asserted-by":"crossref","unstructured":"Hogevik H, Olaison L, Andersson R, et al. Epidemiologic aspects of infective endocarditis in an urban population. Medicine.\u20081995;74:324\u2013339","DOI":"10.1097\/00005792-199511000-00003"},{"key":"2021121010043132300_R5","doi-asserted-by":"crossref","unstructured":"Van der Meer JTM, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial endocarditis in The Netherlands. I. Patient characteristics. Arch Intern Med.\u20081992;152:1863\u20131868","DOI":"10.1001\/archinte.152.9.1863"},{"key":"2021121010043132300_R6","doi-asserted-by":"crossref","unstructured":"Schollin J, Bjarke B, Wesstrom G. Infective endocarditis in Swedish children. I. Incidence, etiology, underlying factors and port of entry of infection. Acta Paediatr Scand.\u20081986;75:993\u2013998","DOI":"10.1111\/j.1651-2227.1986.tb10329.x"},{"key":"2021121010043132300_R7","doi-asserted-by":"crossref","unstructured":"Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Circulation.\u20081997;96:358\u2013366","DOI":"10.1161\/01.CIR.96.1.358"},{"key":"2021121010043132300_R8","doi-asserted-by":"crossref","unstructured":"AAP Committee on Quality Improvement Subcommittee on Urinary Tract Infection. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Pediatrics.\u20081999;103:843\u2013852","DOI":"10.1542\/peds.103.4.843"},{"key":"2021121010043132300_R9","doi-asserted-by":"crossref","unstructured":"Pollack CV, Pollack ES, Andrew ME. Suprapubic bladder aspiration versus urethral catheterization in ill infants: success, efficiency, and complication rates. Ann Emerg Med.\u20081994;23:225\u2013230","DOI":"10.1016\/S0196-0644(94)70035-4"},{"key":"2021121010043132300_R10","unstructured":"Muenning P. Designing and Conducting Cost-Effectiveness Analyses in Medicine and Health Care. San Francisco, CA: Jossey-Bass; 2002"},{"key":"2021121010043132300_R11","doi-asserted-by":"crossref","unstructured":"Roberts GJ, Gardner P, Simmons NA. Optimum sampling time for detection of dental bacteraemia in children. Int J Cardiol.\u20081992;35:311\u2013315","DOI":"10.1016\/0167-5273(92)90228-U"},{"key":"2021121010043132300_R12","unstructured":"Durack DT, Beeson PB. Experimental bacterial endocarditis. II. Survival of bacteria in endocardial vegetations. Br J Exp Pathol.\u20081975;53:50\u201353"},{"key":"2021121010043132300_R13","doi-asserted-by":"crossref","unstructured":"Durack DT. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J Pathol.\u20081975;115:81\u201389","DOI":"10.1002\/path.1711150204"},{"key":"2021121010043132300_R14","doi-asserted-by":"crossref","unstructured":"Hoberman A, Chao HP, Keller DM, et al. Prevalence of urinary tract infection in febrile infants. J Pediatr.\u20081993;123:17\u201323","DOI":"10.1016\/S0022-3476(05)81531-8"},{"key":"2021121010043132300_R15","doi-asserted-by":"crossref","unstructured":"Shaw KN, Gorelick M, McGowan KL, et al. Prevalence of UTI in febrile young children in the emergency department. Pediatrics.\u20081998;102:1\u20135","DOI":"10.1542\/peds.102.2.e16"},{"key":"2021121010043132300_R16","doi-asserted-by":"crossref","unstructured":"Roberts KB, Charney E, Sweren RJ, et al. Urinary tract infection in infants with unexplained fever: a collaborative study. J Pediatr.\u20081983;103:864\u2013867","DOI":"10.1016\/S0022-3476(83)80702-1"},{"key":"2021121010043132300_R17","doi-asserted-by":"crossref","unstructured":"Fukushige J, Igarashi H, Ueda K. Spectrum of infective endocarditis during infancy and childhood: 20-year review. Pediatr Cardiol.\u20081994;15:127\u2013131","DOI":"10.1007\/BF00796324"},{"key":"2021121010043132300_R18","doi-asserted-by":"crossref","unstructured":"Van Hare GF, Ben-Shachar G, Liebman J, et al. Infective endocarditis in infants and children during the past 10 years: a decade of change. Am Heart J.\u20081984;107:1235\u20131240","DOI":"10.1016\/0002-8703(84)90283-7"},{"key":"2021121010043132300_R19","doi-asserted-by":"crossref","unstructured":"Honkinen O, Jahnukainen T, Mertsola J, et al. Bacteremic urinary tract infection in children. Pediatr Infect Dis J.\u20082000;19:630\u2013634","DOI":"10.1097\/00006454-200007000-00009"},{"key":"2021121010043132300_R20","doi-asserted-by":"crossref","unstructured":"Hoberman A, Wald ER, Hickey RW, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics.\u20081999;104:79\u201386","DOI":"10.1542\/peds.104.1.79"},{"key":"2021121010043132300_R21","doi-asserted-by":"crossref","unstructured":"Allan WR, Kumar A. Prophylactic mezlocillin for transurethral prostatectomy. Br J Urol.\u20081985;57:46\u201349","DOI":"10.1111\/j.1464-410X.1985.tb08983.x"},{"key":"2021121010043132300_R22","doi-asserted-by":"crossref","unstructured":"Bor DH, Himmelstein DU. Endocarditis prophylaxis for patients with mitral valve prolapse: a quantitative analysis. Am J Med.\u20081984;76:711\u2013717","DOI":"10.1016\/0002-9343(84)90300-0"},{"key":"2021121010043132300_R23","doi-asserted-by":"crossref","unstructured":"Clemens JD, Ransohoff DF. A quantitative assessment of pre-dental antibiotic prophylaxis for patients with mitral-valve prolapse. J Chron Dis.\u20081984;37:531\u2013544","DOI":"10.1016\/0021-9681(84)90004-3"},{"key":"2021121010043132300_R24","doi-asserted-by":"crossref","unstructured":"Slade N. Bacteraemia and septicaemia after urological operations. Proc R Soc Med.\u20081958;51:331\u2013334","DOI":"10.1177\/003591575805100507"},{"key":"2021121010043132300_R25","doi-asserted-by":"crossref","unstructured":"Sullivan NM, Sutter VL, Mims MM, et al. Clinical aspects of bacteremia after manipulation of the genitourinary tract. J Infect Dis.\u20081973;127:49\u201355","DOI":"10.1093\/infdis\/127.1.49"},{"key":"2021121010043132300_R26","doi-asserted-by":"crossref","unstructured":"Everett ED, Hirschmann JV. Transient bacteremia and endocarditis prophylaxis. A review. Medicine.\u20081977;56:61\u201377","DOI":"10.1097\/00005792-197756010-00004"},{"key":"2021121010043132300_R27","unstructured":"Idsoe O, Guthe T, Willcox RR, DeWeck A. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ.\u20081968;38:159\u2013188"},{"key":"2021121010043132300_R28","doi-asserted-by":"crossref","unstructured":"Cunha BA. Vancomycin. Med Clin North Am.\u20081995;79:817\u2013831","DOI":"10.1016\/S0025-7125(16)30041-4"},{"key":"2021121010043132300_R29","doi-asserted-by":"crossref","unstructured":"Lortholary O, Tod M, Cohen Y, Petitjean O. Aminoglycosides. Med Clin North Am.\u20081995;79:761\u2013787","DOI":"10.1016\/S0025-7125(16)30038-4"},{"key":"2021121010043132300_R30","doi-asserted-by":"crossref","unstructured":"Gold MR, Franks P, McCoy KI, Fryback DG. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care.\u20081998;36:778\u2013792","DOI":"10.1097\/00005650-199806000-00002"},{"key":"2021121010043132300_R31","unstructured":"CDC. National Center for Health Statistics. National Vital Statistics Report. Available at: www.cdc.gov"},{"key":"2021121010043132300_R32","unstructured":"Medical Economics Staff. Drug Topics Red Book. Montvale, NJ: Medical Economics; 2001"},{"key":"2021121010043132300_R33","unstructured":"US Department of Labor. Bureau of Labor Statistics. Bureau of Labor Statistics Data. Available at: www.bls.gov"},{"key":"2021121010043132300_R34","unstructured":"US Department of Labor. Bureau of Labor Statistics. National Compensation Survey: Occupational Wages in the United States, 2000. Available at: www.bls.gov"},{"key":"2021121010043132300_R35","doi-asserted-by":"crossref","unstructured":"Williams RM. The costs of visits to emergency departments. N Engl J Med.\u20081996;334:642\u2013646","DOI":"10.1056\/NEJM199603073341007"},{"key":"2021121010043132300_R36","unstructured":"Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project. HCUPnet Database Selection. Available at: http:\/\/hcup.ahrq.gov\/HCUPnet.asp"},{"key":"2021121010043132300_R37","unstructured":"Starke J. Infective endocarditis. In: Feigin RD, Cherry JD, eds. Pediatric Infectious Diseases. 4th ed. Philadelphia, PA: WB Saunders Company; 1998:315\u2013338"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/113\/5\/1291\/1003494\/zpe00504001291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/113\/5\/1291\/1003494\/zpe00504001291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:40:50Z","timestamp":1682746850000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/113\/5\/1291\/66648\/A-Cost-Effectiveness-Analysis-of-Bacterial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,1]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2004,5,1]]},"published-print":{"date-parts":[[2004,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.113.5.1291","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,1]]}}}